Utama › Mieloma Pelbagai › New York › Greenburgh
Kajian klinikal Mieloma Pelbagai di Greenburgh, NY
13 kajian untuk Mieloma Pelbagai sedang mencari peserta di lokasi dalam dan sekitar Greenburgh (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
A Study of Melphalan With or Without Siltuximab in People With Multiple Myeloma Having an Autologous Stem Cell Transplant
Mengambil pesertaFasa 2
- Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale · 9 mi jauh
A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant
Mengambil pesertaFasa 3
- MSK Bergen, Montvale · 9 mi jauh
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Mengambil pesertaFasa 2
- Phelps Hospital, Sleepy Hollow · 4 mi jauh
Study of IgPro20 to Prevent Infection in People With Multiple Myeloma and Hypogammaglobulinemia
Mengambil pesertaFasa 2
- Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale · 9 mi jauh
A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments
Mengambil pesertaFasa 3
- MSK Bergen, Montvale · 9 mi jauh
A Study of Teclistamab and Mezigdomide in People With Multiple Myeloma
Mengambil pesertaFasa 1
- Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale · 9 mi jauh
A Study of Voice as a Way to Monitor for Side Effects in People Receiving CAR T-Cell Therapy
Mengambil pesertaKajian pemerhatian
- Memorial Sloan Kettering Bergen (Consent Only), Montvale · 9 mi jauh
A Study of Dara-RVd and Teclistamab-RVd in People With Multiple Myeloma
Mengambil pesertaFasa 1/2
- Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale · 9 mi jauh
A Study of CyBorD (Cyclophosphamide, Bortezomib, Dexamethasone) Plus Daratumumab in People With Monoclonal Gammopathy of Renal Significance (MGRS)
Mengambil pesertaFasa 2
- Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale · 9 mi jauh
A Study of Elranatamab and Cyclophosphamide in People With Multiple Myeloma
Mengambil pesertaFasa 2
- Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale · 9 mi jauh
A Dietary Study for People With Multiple Myeloma
Mengambil peserta
- Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale · 9 mi jauh
A Study of Talquetamab for People With Multiple Myeloma Who Have Received BCMA CAR T-Cell Therapy
Mengambil pesertaFasa 2
- Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale · 9 mi jauh
A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)
Mengambil peserta
- Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale · 9 mi jauh
Kajian Mieloma Pelbagai di bandar lain
- New York City, NY60 kajian
- Boston, MA42 kajian
- Atlanta, GA41 kajian
- Houston, TX38 kajian
- Durham, NC37 kajian
- Nashville, TN32 kajian
- Denver, CO27 kajian
- Rochester, MN24 kajian
- St. Louis, MO24 kajian
- Columbus, OH24 kajian
- Baldwin Park, CA23 kajian
- Chicago, IL22 kajian
Kajian lain di Greenburgh
- Kanser Payudara42 kajian
- Kanser Paru-paru Bukan Sel Kecil28 kajian
- Leukemia Mieloid Akut18 kajian
- Kanser Prostat17 kajian
- Kanser (semua jenis)17 kajian
- Kanser Paru-paru17 kajian
- Kanser Kolorektal11 kajian
- Kanser Metastatik11 kajian
- Kanser Endometrium11 kajian
- Kanser Pundi Kencing10 kajian
- Karsinoma Sel Skuamosa Kepala dan Leher9 kajian
- Limfoma9 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.